Is UroGen Pharma Ltd. (URGN) a Buy, Sell, or Hold?
UroGen Pharma Ltd.
NASDAQ:URGN
$39.8 USD
$0.61 (1.56%)
- Volume
- 882.7K
- Average Volume
- 814.44K
- Market Capitalization
- $1.94B
- P/E Ratio
- -14.47
- Dividend Yield
- 0.00%
- Price Target
- $44.00
- Year High
- $40.87
- Year Low
- $14.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.69
Analyst Rating
Sell
2 Rating Score
UPSIDE/DOWNSIDE
-9.5% DOWNSIDE
$44.00 Price Target
UPSIDE/DOWNSIDE HIGH
-11.6% DOWNSIDE
$45.00 Price Target High
UPSIDE/DOWNSIDE LOW
-0.5% DOWNSIDE
$40.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| H.C. Wainwright | Raghuram Selvaraju | $45 | $29.4 | 2026-05-11 06:11 AM | 53.1% |
| Jefferies | Amin Makarem | $40 | $20.53 | 2026-04-09 04:21 PM | 94.8% |
| Goldman Sachs | Paul Choi | $16 | $12.03 | 2025-06-13 06:15 PM | 33.0% |
| Oppenheimer | Leland Gershell | $31 | $12.03 | 2025-06-13 03:24 PM | 157.7% |
| EF Hutton | Jason Kolbert | $25 | $12.6 | 2024-10-14 03:13 AM | 98.4% |
| Evercore ISI | Stephen Richardson | $46 | $20.26 | 2024-06-14 04:30 AM | 127.0% |
| Oppenheimer | Leland Gershell | $40 | $17.5 | 2024-06-14 03:43 AM | 128.6% |
| H.C. Wainwright | Raghuram Selvaraju | $60 | $17.5 | 2024-06-14 02:14 AM | 242.9% |
| Goldman Sachs | Paul Choi | $22 | $17.5 | 2024-06-14 01:11 AM | 25.7% |